Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-26 @ 2:24 AM
Study NCT ID:
NCT00106002
Status:
COMPLETED
Last Update Posted:
2009-06-01
First Post:
2005-03-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
2007-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-03-18
First Submit QC Date:
None
Study First Post Date:
2005-03-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2008-12-23
Results First Submit QC Date:
None
Results First Post Date:
2009-06-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-05-29
Last Update Post Date:
2009-06-01
Last Update Post Date Type:
ESTIMATED